Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Breast Neoplasms 6Prostatic Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Radiodermatitis 2Pancreatic Neoplasms 2Pain 2Neoplasms 2Multiple Myeloma 2Breast Carcinoma In Situ 2Adenomatous Polyposis Coli 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Stomatitis 1Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Monoclonal Gammopathy of Undetermined Significance 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Fatigue 1Endometrial Neoplasms 1Condylomata Acuminata 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma 1Adenocarcinoma 1

Interventions

Lenalidomide 7Dexamethasone 5Calcium Dobesilate 4elotuzumab 2Denosumab 2siltuximab 1piperine 1ixazomib 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Urination 1Receptors, Interleukin-6 1Peripheral Blood Stem Cell Transplantation 1PVX-410 vaccine 1Nivolumab 1Melphalan 1Maintenance 1Interleukin 1 Receptor Antagonist Protein 1In Situ Hybridization, Fluorescence 1Immunotherapy, Active 1IPH-2101 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cytogenetic Analysis 1Cyclophosphamide 1Curcumin 1Celecoxib 1BHQ880 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Smoldering Multiple Myeloma × Curcumin × Clear all
NCT04731844 2026-05-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

University of Rochester

Phase 2 Completed
30 enrolled 13 charts
GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡